Krzysztof Marciniec

14PUBLICATIONS
35CO-AUTHORS
Biomolecular modelling and designNanotoxicology, health and safetySocial epidemiologyToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 26, 2026
Novel Lomefloxacin-Triazole Hybrids: Design, Synthesis and In Vitro Antiproliferative Activity in Breast, Melanoma and Colon Cancer Cell Lines.

|May 04, 2026
Nanocarrier-Based Therapeutic Strategies in Myocardial Ischemia-Reperfusion Injury: A Systematic Review of Preclinical Evidence.

|Sep 27, 2025
Effect of Tigecycline on the Homeostasis of Human Epidermal Melanocytes and Fibroblasts.

Zuzanna Rzepka, Marta Karkoszka-Stanowska, Krzysztof Marciniec

|Mar 11, 2025
Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models.

Anna Partyka, Joanna Gołębiowska, Krzysztof Marciniec

|Feb 26, 2025
Novel Method for the Synthesis of Hydroxycobalamin[c-lactam] and Its Impact on Melanoma Cells In Vitro.

Zuzanna Rzepka, Magdalena Janus, Krzysztof Marciniec

|Sep 14, 2024
Short Communication: Novel Di- and Triselenoesters as Effective Therapeutic Agents Inhibiting Multidrug Resistance Proteins in Breast Cancer Cells.

Dominika Radomska, Robert Czarnomysy, Krzysztof Marciniec

Pageof 3

Frequent Collaborators

4 joint publications

Zuzanna Rzepka

4 joint publications

Dorota Wrześniok

3 joint publications

Elwira Chrobak

3 joint publications

Vittorio Canale